Evidence map›Paper›PMID 35847267›Full record

ArticleACS omega2022

Human Microglia Extracellular Vesicles Derived from Different Microglia Cell Lines: Similarities and Differences.

Lorenzo Ceccarelli, Laura Marchetti, Milena Rizzo, Aldo Moscardini, Valentina Cappello, Eleonora Da Pozzo, Miriam Romano, Chiara Giacomelli, Paolo Bergese, Claudia Martini

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Lorenzo CeccarelliDepartment of Pharmacy, University of Pisa, Pisa 56126, Italy.
Laura MarchettiDepartment of Pharmacy, University of Pisa, Pisa 56126, Italy.ORCID https://orcid.org/0000-0002-2110-9481
Milena RizzoInstitute of Clinical Physiology (IFC), CNR, Pisa 56124, Italy.
Aldo MoscardiniSNS (Scuola Normale Superiore, NEST laboratories), Pisa 56127, Italy.
Valentina CappelloCenter for Materials Interfaces, Electron Crystallography, Istituto Italiano di Tecnologia, Pontedera 56025, Italy.
Eleonora Da PozzoDepartment of Pharmacy, University of Pisa, Pisa 56126, Italy.ORCID https://orcid.org/0000-0003-4762-8949
Miriam RomanoDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25121, Italy.
Chiara GiacomelliDepartment of Pharmacy, University of Pisa, Pisa 56126, Italy.
Paolo BergeseDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25121, Italy.ORCID https://orcid.org/0000-0002-4652-2168
Claudia MartiniDepartment of Pharmacy, University of Pisa, Pisa 56126, Italy.ORCID https://orcid.org/0000-0001-9379-3027
University of Pisa · ITConsorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase · ITIstituto di Fisiologia Clinica · ITItalian Institute of Technology · ITScuola Normale Superiore · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglial cells are a component of the innate immune system in the brain that support cell-to-cell communication via secreted molecules and extracellular vesicles (EVs). EVs can be divided into two major populations: large (LEVs) and small (SEVs) EVs, carrying different mediators, such as proteins, lipids, and miRNAs. The microglia EVs cargo crucially reflects the status of parental cells and can lead to both beneficial and detrimental effects in many physiopathological states. Herein, a workflow for the extraction and characterization of SEVs and LEVs from human C20 and HMC3 microglia cell lines derived, respectively, from adult and embryonic microglia is reported. EVs were gathered from the culture media of the two cell lines by sequential ultracentrifugation steps and their biochemical and biophysical properties were analyzed by Western blot, transmission electron microscopy, and dynamic light scattering. Although the C20- and HMC3-derived EVs shared several common features, C20-derived EVs were slightly lower in number and more polydispersed. Interestingly, C20- but not HMC3-SEVs were able to interfere with the proliferation of U87 glioblastoma cells. This correlated with the different relative levels of eight miRNAs involved in neuroinflammation and tumor progression in the C20- and HMC3-derived EVs, which in turn reflected a different basal activation state of the two cell types. Our data fill a gap in the community of microglia EVs, in which the preparations from human cells have been poorly characterized so far. Furthermore, these results shed light on both the differences and similarities of EVs extracted from different human microglia cell models, underlining the need to better characterize the features and biological effects of EVs for therein useful and correct application.

Identifiers

PMID35847267
PMCPMC9280972
OpenAlexW4283695380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.